FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Animals : an open access journal from MDPI2024; 14(15); 2250; doi: 10.3390/ani14152250

The Effects of Intra-Articular Triamcinolone and Autologous Protein Solution on Metabolic Parameters in Horses.

Abstract: Intra-articular corticosteroids are a popular treatment choice for joint-associated pain and inflammation in horses despite recent work on the metabolic effects of these drugs. The goal of this project was to compare metabolic effects between intra-articular (IA) triamcinolone acetonide (TA) and an autologous protein solution (APS). Five mixed-breed geldings (4-9 years) were utilized for this project. Three identical and consecutive 28-day treatment blocks were used, with metacarpophalangeal IA treatments consisting of equal volumes of saline, a commercially available APS, or 9 mg of TA. Regular plasma and serum samples were collected for ACTH, cortisol, glucose, insulin, and thyroid hormone analysis, in addition to thyrotropin-releasing hormone (TRH) and oral sugar tests (OSTs). Significant treatment effects of IA TA were present at 48 h post-injection in both the TRH and the OST. There was also significant suppression by IA TA of baseline ACTH and cortisol between 2 h and 96 h post-treatment, hyperglycemia between 12 h and 48 h, and hyperinsulinemia at 32 h post-treatment. There were no treatment effects with respect to any measured thyroid hormones, nor were there any significant treatment effects of APS noted. Results suggest at least 2 days and up to 7 days should elapse between a single 9 mg IA TA treatment and OST and/or TRH testing. This study found that TA exhibits significant effects on ACTH, cortisol, glucose, and insulin, while the APS does not.
Get Full Text
Publication Date: 2024-08-02 PubMed ID: 39123776PubMed Central: PMC11311071DOI: 10.3390/ani14152250Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study explores the metabolic effects of intra-articular corticosteroids, specifically Triamcinolone Acetonide (TA), compared to Autologous Protein Solution (APS) treatment on horses. The paper specifically highlights that while TA showed marked effects on ACTH, cortisol, glucose, and insulin, APS treatment did not.

Methodology

The study used five mixed-breed geldings aged between 4 and 9 years. Researchers organized three consecutive 28-day treatment blocks, in which each block saw the use of intra-articular treatments of saline, APS and an amount of 9mg TA. The treatments were injected into the metacarpophalangeal IA of the horses.

  • Samples of serum and plasma were collected routinely for testing levels thyroid hormones, ACTH (adrenocorticotropic hormone), cortisol, glucose, and insulin.
  • Thyrotropin-releasing hormone (TRH) and oral sugar tests (OSTs) were performed to monitor the metabolic effects of the treatments.

Results

  • Potential treatment effects of TA were detected 48 hours post-injection with both OST and TRH tests.
  • The study found TA had a suppressive effect on the baseline secretion of ACTH and cortisol. This effect was measured between 2 hours and 96 hours after the treatment was applied.
  • Hyperglycemia (high blood sugar) was observed between 12 and 48 hours, and Hyperinsulinemia (excess levels of insulin) was observed to peak at 32 hours post-treatment.
  • There were no treatment effects detected in terms of thyroid hormones.
  • Regarding the APS treatment, there were no notable treatment effects observed.

Conclusions

  • The study concluded that TA treatment has noteworthy effects on ACTH, cortisol, glucose, and insulin levels in horses.
  • There were no observed significant effects from the APS treatment.
  • The study suggests that between treatments of single 9 mg IA TA and OST and/or TRH testing, a period of at least 2 days and up to 7 days should elapse to properly monitor the effects.

Cite This Article

APA
Page AE, Johnson M, Parker JL, Jacob O, Poston R, Adams AA, Adam EN. (2024). The Effects of Intra-Articular Triamcinolone and Autologous Protein Solution on Metabolic Parameters in Horses. Animals (Basel), 14(15), 2250. https://doi.org/10.3390/ani14152250

Publication

Animals : an open access journal from MDPI
ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 14
Issue: 15
PII: 2250

Researcher Affiliations

Page, Allen E
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Johnson, Mackenzie
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Parker, Jordan L
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Jacob, Olivia
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Poston, Rachel
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Adams, Amanda A
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Adam, Emma N
  • Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.

Grant Funding

  • N/A / Zoetis (United States)

Conflict of Interest Statement

This project was funded by Zoetis, LLC. While this manuscript was provided to the company prior to publication, the study design, data analysis, and interpretation of results are solely those of the authors.

References

This article includes 28 references
  1. Zanotto G.M., Frisbie D.D.. Current joint therapy usage in equine practice: Changes in the last 10 years.. Equine Vet. J. 2022;54:750–756.
    doi: 10.1111/evj.13489pubmed: 34143532google scholar: lookup
  2. Hammersley E., Duz M., Marshall J.F.. Triamcinolone Administration Does Not Increase Overall Risk of Developing Laminitis.. Equine Vet. J. 2015;47:24.
    doi: 10.1111/evj.12486_54pubmed: 26375178google scholar: lookup
  3. Potter K., Stevens K., Menzies-Gow N.. Prevalence of and risk factors for acute laminitis in horses treated with corticosteroids.. Vet. Rec. 2019;185:82.
    doi: 10.1136/vr.105378pubmed: 31175222google scholar: lookup
  4. Haseler C.J., Jarvis G.E., McGovern K.F.. Intrasynovial triamcinolone treatment is not associated with incidence of acute laminitis.. Equine Vet. J. 2021;53:895–901.
    doi: 10.1111/evj.13361pubmed: 33174264google scholar: lookup
  5. Coleman M.C., Belknap J.K., Eades S.C., Galantino-Homer H.L., Hunt R.J., Geor R.J., McCue M.E., McIlwraith C.W., Moore R.M., Peroni J.F.. Case-control study of risk factors for pasture-and endocrinopathy-associated laminitis in North American horses.. J. Am. Vet. Med. Assoc. 2018;253:470–478.
    doi: 10.2460/javma.253.4.470pubmed: 30058970google scholar: lookup
  6. Boger B.L., Manfredi J.M., Loucks A.R., Salamey M.Z., Kapeller L.E., Fricano A.G., Winkler A., Yob C., Colbath A.C.. Intra-articular triamcinolone acetonide injection results in increases in systemic insulin and glucose concentrations in horses without insulin dysregulation.. Equine Vet. J. 2023;56:326–331.
    doi: 10.1111/evj.14003pubmed: 37705233google scholar: lookup
  7. Ireland J.L., McGowan C.M.. Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors.. Vet. J. 2018;235:22–33.
    doi: 10.1016/j.tvjl.2018.03.002pubmed: 29704935google scholar: lookup
  8. Ballou M.E., Mueller M.K., Dowling-Guyer S.. Aging Equines: Understanding the Experience of Caring for a Geriatric Horse with a Chronic Condition.. J. Equine Vet. Sci. 2020;90:102993.
    doi: 10.1016/j.jevs.2020.102993pubmed: 32534771google scholar: lookup
  9. Tatum R.C., McGowan C.M., Dean R.S., Ireland J.L.. Equine pituitary pars intermedia dysfunction: Identifying research priorities for diagnosis, treatment and prognosis through a priority setting partnership.. PLoS ONE 2021;16:e0244784.
    doi: 10.1371/journal.pone.0244784pmc: PMC7781667pubmed: 33395695google scholar: lookup
  10. Al-Ansari A.S., Golding E., Walshe N., Mooney C.T., Duggan V.. Obesity and obesity-associated metabolic disease conditions in Connemara ponies in Ireland.. Equine Vet. J. 2024;56:273–280.
    doi: 10.1111/evj.14029pubmed: 37985219google scholar: lookup
  11. Partridge E., Adam E., Wood C., Parker J., Johnson M., Horohov D., Page A.. Residual effects of intra-articular betamethasone and triamcinolone acetonide in an equine acute synovitis model.. Equine Vet. J. 2023;55:905–915.
    doi: 10.1111/evj.13899pubmed: 36397207google scholar: lookup
  12. Hallowell K.L., Dembek K., Horne C.R., Knych H.K., Messenger K.M., Schnabel L.V.. Systemic absorption of triamcinolone acetonide is increased from intrasynovial versus extrasynovial sites and induces hyperglycemia, hyperinsulinemia, and suppression of the hypothalamic-pituitary-adrenal axis.. Front. Vet. Sci. 2024;11:1388470.
    doi: 10.3389/fvets.2024.1388470pmc: PMC11141165pubmed: 38828366google scholar: lookup
  13. Bertone A.L., Ishihara A., Zekas L.J., Wellman M.L., Lewis K.B., Schwarze R.A., Barnaba A.R., Schmall M.L., Kanter P.M., Genovese R.L.. Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses.. Am. J. Vet. Res. 2014;75:141–151.
    doi: 10.2460/ajvr.75.2.141pubmed: 24471750google scholar: lookup
  14. Hart K., Durham A., Frank N., McGowan C.M., Schott II H.C., Stewart A.. Recommendations for the Diagnosis and Treatment of Pituitary Pars Intermedia Dysfunction; Equine Endocrinology Group.. 2021.
  15. Frank N., Bailey S., Bertin F.-R., Burns T., de Laat M., Durham A., Kritchevsky J., Menzies-Gow N.. Recommendations for the Diagnosis and Management of Equine Metabolic Syndrome (EMS); Equine Endocrinology Group.. 2022.
  16. Velineni S., Cowles B., Wilson G., Schiltz P., Chang K., Peng Y.. Accuracy of a Point-of-Care, Species-Specific Blood Glucose Monitoring System for Use in Horses. Proceedings of the American Association of Equine Practitioners San Diego, CA, USA. 29 November–3 December 2023; pp. 443–444.
  17. [(accessed on 7 March 2023)]. Available online: http://www.openepi.com/SampleSize/SSMean.htm.
  18. Iranmanesh A., Gullapalli D., Singh R., Veldhuis J.D.. Hypothalamo-pituitary-adrenal axis after a single epidural triamcinolone injection.. Endocrine 2017;57:308–313.
    doi: 10.1007/s12020-017-1357-7pmc: PMC5554884pubmed: 28674775google scholar: lookup
  19. Soma L.R., Uboh C.E., You Y., Guan F., Boston R.C.. Pharmacokinetics of intra-articular, intravenous, and intramuscular administration of triamcinolone acetonide and its effect on endogenous plasma hydrocortisone and cortisone concentrations in horses.. Am. J. Vet. Res. 2011;72:1234–1242.
    doi: 10.2460/ajvr.72.9.1234pubmed: 21879982google scholar: lookup
  20. Chen C.L., Sailor J.A., Collier J., Wiegand J.. Synovial and serum levels of triamcinolone following intra-articular administration of triamcinolone acetonide in the horse*.. J. Vet. Pharmacol. Ther. 1992;15:240–246.
    doi: 10.1111/j.1365-2885.1992.tb01012.xpubmed: 1433486google scholar: lookup
  21. Macon E.L., Harris P., Barker V.D., Adams A.A.. Seasonal Insulin Responses to the Oral Sugar Test in Healthy and Insulin Dysregulated Horses.. J. Equine Vet. Sci. 2022;113:103945.
    doi: 10.1016/j.jevs.2022.103945pubmed: 35405290google scholar: lookup
  22. Hale J.N., Hughes K.J., Hall S., Labens R.. The effect of exercise on cytokine concentration in equine autologous conditioned serum.. Equine Vet. J. 2023;55:551–556.
    doi: 10.1111/evj.13586pubmed: 35569120google scholar: lookup
  23. Fjordbakk C., Johansen G., Løvås A., Oppegård K., Storset A.. Surgical stress influences cytokine content in autologous conditioned serum.. Equine Vet. J. 2015;47:212–217.
    doi: 10.1111/evj.12277pubmed: 24735323google scholar: lookup
  24. Gilbertie J., Davis J., Davidson G., McDonald A., Schirmer J., Schnabel L.. Oral reserpine administration in horses results in low plasma concentrations that alter platelet biology.. Equine Vet. J. 2019;51:537–543.
    doi: 10.1111/evj.13048pubmed: 30465727google scholar: lookup
  25. Abraham G., Allersmeier M., Schusser G.F., Ungemach F.R.. Serum thyroid hormone, insulin, glucose, triglycerides and protein concentrations in normal horses: Association with topical dexamethasone usage.. Vet. J. 2011;188:307–312.
    doi: 10.1016/j.tvjl.2010.05.033pubmed: 20594877google scholar: lookup
  26. Messer N.T., Ganjam V.K., Nachreiner R.F., Krause G.F.. Effect of dexamethasone administration on serum thyroid hormone concentrations in clinically normal horses.. J. Am. Vet. Med. Assoc. 1995;206:63–66.
    doi: 10.2460/javma.1995.206.01.63pubmed: 7744665google scholar: lookup
  27. Knych H.K., Vidal M.A., Chouicha N., Mitchell M., Kass P.H.. Cytokine, catabolic enzyme and structural matrix gene expression in synovial fluid following intra-articular administration of triamcinolone acetonide in exercised horses.. Equine Vet. J. 2017;49:107–115.
    doi: 10.1111/evj.12531pubmed: 26518341google scholar: lookup
  28. Knych H.K., Vidal M.A., Casbeer H.C., McKemie D.S.. Pharmacokinetics of triamcinolone acetonide following intramuscular and intra-articular administration to exercised Thoroughbred horses.. Equine Vet. J. 2013;45:715–720.
    doi: 10.1111/evj.12059pubmed: 23574452google scholar: lookup

Citations

This article has been cited 1 times.
  1. Carmona JU, López C. Platelet-Rich Plasma in Equine Osteoarthritis: A Systematic Review of Clinical and Experimental Evidence. Animals (Basel) 2025 Sep 9;15(18).
    doi: 10.3390/ani15182647pubmed: 41007891google scholar: lookup
Subscribe to our newsletter
Join 99,780 horse owners like you who receive our email updates on horse health and nutrition.